Homepage
Author:
SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
Posted Date:
May 28, 2026
Aphranel® MagiCCrystal CaHA Filler Achieves EU MDR Certification as a Premium Regenerative Injectable
SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
May 28, 2026
Aphranel Hosts “The Poetics of Time” Cultural Forum at Rome Exhibition in Shanghai
SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
May 20, 2026
Aphranel Founder Invited by People’s Daily to Discuss Long-Term Development in China’s Medical Aesthetics Sector
SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
March 30, 2026
Aphranel Named to Forbes China Beauty 100 List
SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
March 13, 2026
Aphranel Launches “The Poetics of Time” Brand Strategy at IMCAS Paris, Redefining Long-Term Value in Medical Aesthetics
SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
February 12, 2026
/C O R R E C T I O N — SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD/
SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
February 5, 2026
Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel’s “Poetics of Time” Brand Positioning
SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
February 3, 2026
